2024/09/20 15:30:00 | |
---|---|
Price | |
515.32 USD | |
Difference | 2.39% (12.03) |
ISIN | US45168D1046 |
Symbol | IDXX |
Exchange | London Stock Exchange |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 37,376 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 515.32 USD |
High | 515.32 USD |
Low | 515.32 USD |
Close (prev. day) | 503.2886 USD |
VWAP | 515.32 USD |
Volume (pcs) | 33 |
Trading volume | 7,214.48 |
Number of trades | 4 |
Last size | 14 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings | ||
2024/07/12 | Global Equity Ratings |
2024/09/20 15:30:00 | |
---|---|
Price | |
515.32 USD | |
Difference | 2.39% (12.03) |
ISIN | US45168D1046 |
Symbol | IDXX |
Exchange | London Stock Exchange |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 37,376 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 515.32 USD |
High | 515.32 USD |
Low | 515.32 USD |
Close (prev. day) | 503.2886 USD |
VWAP | 515.32 USD |
Volume (pcs) | 33 |
Trading volume | 7,214.48 |
Number of trades | 4 |
Last size | 14 |
6m | 1Y | 3Y | |
Perf (%) | - | - | - |
Perf (abs.) | - | - | - |
Beta | 0.99 | 1.17 | 1.27 |
Volatility | - | 0.10 | 4.47 |
Ø price 5 days | Ø volume 5 days (pcs.) | 509.30 USD (52) |
Ø price 30 days | Ø volume 30 days (pcs.) | 494.03 USD (53) |
Ø price 100 days | Ø volume 100 days (pcs.) | 487.86 USD (287) |
Ø price 250 days | Ø volume 250 days (pcs.) | 502.94 USD (317) |
YTD High | date | 570.40 USD (2024/02/26) |
YTD Low | date | 455.08 USD (2024/08/06) |
52 Weeks High | date | 570.40 USD (2024/02/26) |
52 Weeks Low | date | 428.94 USD (2023/10/23) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/09/20 | 17:35 | 455.40 EUR | 0.00 | 2 |
Vienna Stock Exchange | 2024/09/20 | 17:32 | 455.50 EUR | 0.00 | 5 |
Tradegate | 2024/09/20 | 22:26 | 453.90 EUR | 0.00 | 2 |
Stuttgart | 2024/09/20 | 21:38 | 453.40 EUR | 0.00 | 5 |
Nasdaq | 2024/09/20 | 22:00 | 506.74 USD | 350.43 | 12,277 |
Munich | 2024/09/20 | 08:01 | 461.00 EUR | 0.00 | 2 |
London Stock Exchange | 2024/09/20 | 15:30 | 515.32 USD | 0.01 | 4 |
Hanover | 2024/09/20 | 17:25 | 455.00 EUR | 0.00 | 4 |
Frankfurt | 2024/09/20 | 08:06 | 460.80 EUR | 0.00 | 3 |
Duesseldorf | 2024/09/20 | 19:31 | 452.20 EUR | 0.00 | 7 |
Berlin | 2024/09/20 | 08:08 | 460.90 EUR | 0.00 | 3 |
IDEXX LABORATORIES INC. |
- - |
One IDEXX Drive - 04092-2040 Westbrook |
Telefon: +1-207-556-0300 |
Fax: +1-207-556-4346 |
E-mail: - |
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME. |
Lawrence Kingsley | Chairman of Board of Directors |
Asha Collins | Member of Board of Directors |
Sophie Vandebroek | Member of Board of Directors |
Stuart Essig | Member of Board of Directors |
Bruce Claflin | Member of Board of Directors |
Daniel Junius | Member of Board of Directors |
Irene Britt | Member of Board of Directors |
Jonathan Ayers | Member of Board of Directors |
M. Szostak | Member of Board of Directors |
Sam Samad | Member of Board of Directors |
Jay Mazelsky | Chairman of Managing Board |
Brian P. McKeon | Member of Executive Committee |
James F. Polewaczyk | Member of Executive Committee |
Ken Grady | Member of Executive Committee |
Martin Smith | Member of Executive Committee |
Michael P. Johnson | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer